1. Home
  2. INBS vs APTO Comparison

INBS vs APTO Comparison

Compare INBS & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • APTO
  • Stock Information
  • Founded
  • INBS 2016
  • APTO 1986
  • Country
  • INBS United States
  • APTO Canada
  • Employees
  • INBS N/A
  • APTO N/A
  • Industry
  • INBS Medical Specialities
  • APTO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INBS Health Care
  • APTO Health Care
  • Exchange
  • INBS Nasdaq
  • APTO Nasdaq
  • Market Cap
  • INBS 6.3M
  • APTO 7.4M
  • IPO Year
  • INBS N/A
  • APTO N/A
  • Fundamental
  • Price
  • INBS $1.55
  • APTO $0.19
  • Analyst Decision
  • INBS
  • APTO Strong Buy
  • Analyst Count
  • INBS 0
  • APTO 3
  • Target Price
  • INBS N/A
  • APTO $4.33
  • AVG Volume (30 Days)
  • INBS 157.9K
  • APTO 700.2K
  • Earning Date
  • INBS 11-07-2024
  • APTO 11-08-2024
  • Dividend Yield
  • INBS N/A
  • APTO N/A
  • EPS Growth
  • INBS N/A
  • APTO N/A
  • EPS
  • INBS N/A
  • APTO N/A
  • Revenue
  • INBS $3,187,974.00
  • APTO N/A
  • Revenue This Year
  • INBS $280.88
  • APTO N/A
  • Revenue Next Year
  • INBS $126.26
  • APTO N/A
  • P/E Ratio
  • INBS N/A
  • APTO N/A
  • Revenue Growth
  • INBS 55.29
  • APTO N/A
  • 52 Week Low
  • INBS $1.00
  • APTO $0.13
  • 52 Week High
  • INBS $11.70
  • APTO $2.91
  • Technical
  • Relative Strength Index (RSI)
  • INBS 49.77
  • APTO 21.08
  • Support Level
  • INBS $1.35
  • APTO $0.35
  • Resistance Level
  • INBS $1.74
  • APTO $0.41
  • Average True Range (ATR)
  • INBS 0.20
  • APTO 0.03
  • MACD
  • INBS -0.01
  • APTO -0.02
  • Stochastic Oscillator
  • INBS 34.53
  • APTO 20.69

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

About APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Share on Social Networks: